In pancreatic cancer, multiple signaling pathways have been shown to cross-talk with the NF-kB signaling pathway, resulting in tumorigenesis, tumor survival, metastasis, or chemoresistance [89]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.